William L. Demers - Jul 6, 2021 Form 4 Insider Report for POINT Biopharma Global Inc. (PNT)

Role
Chief Financial Officer
Signature
/s/ William L. Demers
Stock symbol
PNT
Transactions as of
Jul 6, 2021
Transactions value $
$0
Form type
4
Date filed
7/8/2021, 04:36 PM
Previous filing
Jun 30, 2021
Next filing
Mar 31, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PNT Stock Option (Right to Buy) Award $0 +16.8K $0.00 16.8K Jul 6, 2021 Common Stock 16.8K $8.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on July 6, 2022 with the remaining 75% vesting in three equal annual installments thereafter.